Over 30% of patients who failed all standard chemo and antibody therapy remain alive after...
December 21, 2015 08:00 AM Eastern Standard Time WASHINGTON--(BUSINESS WIRE)-- Today Precision Biologics Inc, a clinical...
Precision Biologics is pleased to announce the addition of Beth Israel Deaconess (BIDMC)as a collaborator...
Precision Biologics is pleased to announce the addition of Dana-Farber/Harvard Cancer Center (DF/HCC) and Massachusetts...
Dr. Philip Arlen will be speaking at this years Drug Discovery Summit June 8-9th in...
FOR IMMEDIATE RELEASE….Rockville, MD, May 20, 2015 Precision Biologics is pleased to announce the completion of...
Precision Biologics is pleased to announce the addition of both Yale Cancer Center at the...
PRECISION BIOLOGICS, INC. NOTICE OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON JUNE 12, 2015 at 6:00...
DARMSTADT, Germany, Feb. 2, 2015 /PRNewswire/ -- EMD Millipore, the Life Science business of Merck KGaA of Darmstadt, today announced an...
Precision Biologics is pleased to announce promising overall survival (OS) data from its ongoing Phase...